Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
RMD Open
|
May 16, 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)
Ai Phuong Tran, Daniel Tassone, Johannes Nossent, et al.
Journal of Gastroenterology and Hepatology
|
May 31, 2024
Systematic review and meta-analysis of endoscopic versus medical management of peptic ulcers with adherent clots
Daniel Tassone, Shamsul Kazi, Tanya Lee, et al.
The American Journal of Geriatric Pharmacotherapy
|
October 24, 2012
Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic
Parinaz K Ghaswalla, Spencer E Harpe, Daniel Tassone, et al.
Internal Medicine Journal
|
February 25, 2021
Immunosuppression as a risk factor for COVID-19: a meta-analysis
Daniel Tassone, Alexander Thompson, William Connell, et al.
American Journal of Infection Control
|
June 3, 2019
Variation in a novel antipseudomonal antimicrobial consumption metric across hospital inpatient units at a Veterans Affairs hospital: A retrospective cohort study
Nicole C Vissichelli, Pamela Bailey, Roy T Sabo, et al.
Journal of Crohn'S & Colitis
|
March 24, 2022
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease
Nik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, et al.
Internal Medicine Journal
|
May 31, 2023
Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
Daniel Tassone, Chamara Basnayake, Emily Wright, et al.
Alimentary Pharmacology & Therapeutics
|
August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss
Simon J Hume, Samuel Hall, Gareth Burns, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
RMD Open
|
May 16, 2022
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE)
Ai Phuong Tran, Daniel Tassone, Johannes Nossent, et al.
Journal of Gastroenterology and Hepatology
|
May 31, 2024
Systematic review and meta-analysis of endoscopic versus medical management of peptic ulcers with adherent clots
Daniel Tassone, Shamsul Kazi, Tanya Lee, et al.
The American Journal of Geriatric Pharmacotherapy
|
October 24, 2012
Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic
Parinaz K Ghaswalla, Spencer E Harpe, Daniel Tassone, et al.
Internal Medicine Journal
|
February 25, 2021
Immunosuppression as a risk factor for COVID-19: a meta-analysis
Daniel Tassone, Alexander Thompson, William Connell, et al.
American Journal of Infection Control
|
June 3, 2019
Variation in a novel antipseudomonal antimicrobial consumption metric across hospital inpatient units at a Veterans Affairs hospital: A retrospective cohort study
Nicole C Vissichelli, Pamela Bailey, Roy T Sabo, et al.
Journal of Crohn'S & Colitis
|
March 24, 2022
Systematic Review: The Impact and Importance of Body Composition in Inflammatory Bowel Disease
Nik Sheng Ding, Daniel Tassone, Ibrahim Al Bakir, et al.
Internal Medicine Journal
|
May 31, 2023
Risk factors for malignancy and serious infection in patients with inflammatory bowel disease: a retrospective analysis
Daniel Tassone, Chamara Basnayake, Emily Wright, et al.
Alimentary Pharmacology & Therapeutics
|
August 22, 2025
Long-Term Follow-Up of Patients in a Prospective Study of NA Discontinuation Identifies Different Patterns of HBsAg Loss
Simon J Hume, Samuel Hall, Gareth Burns, et al.
Internal Medicine Journal
|
September 5, 2024
6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy
Natalie Yu, Tanya Lee, Daniel Tassone, et al.
Page
of 1